Position
President
Company
Gain Therapeutics
BethesdaBiotechnologyHealth CareTherapeuticsDescription
Gain Therapeutics, Inc. appointed Gene Mack, the Company’s current Chief Financial Officer, as interim Chief Executive Officer, effective June 25, 2024. Khalid Islam, Ph.D., founder and Chairman of the Board, will serve as Executive Chairman until a permanent CEO is appointed.
Quick answer
Gain Therapeutics, Inc. Appoints Gene Mack as Interim CEO (June 27, 2024). Gain Therapeutics is based in Bethesda, Maryland, United States.
- Who is the new President at Gain Therapeutics?
- Gain Therapeutics named Gene Mack President, announced June 27, 2024.
- What did Gain Therapeutics announce on June 27, 2024?
- Gain Therapeutics, Inc. appointed Gene Mack, the Company’s current Chief Financial Officer, as interim Chief Executive Officer, effective June 25, 2024. Khalid Islam, Ph.D., founder and Chairman of the Board, will serve as Executive Chairman until a permanent CEO is appointed.
- What does Gain Therapeutics do?
- Gain Therapeutics, Inc. is a clinical-stage biotechnology company leading the discovery and development of next generation allosteric therapies.
- Where is Gain Therapeutics based?
- Gain Therapeutics is based in Bethesda, Maryland, United States.
- Which similar companies made leadership changes around the same time?
- Immunome Inc. (June 27, 2024), Actym Therapeutics (June 25, 2024), MBX Biosciences, Inc. (June 25, 2024) and Arvinas (June 24, 2024) also announced leadership changes within 45 days of Gain Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Immunome Appoints Phil Tsai, PhD, as Chief Technical Officer (June 27, 2024)
- Actym Therapeutics Appoints Mary J. Janatpour as Chief Scientific Officer and Shouryadeep Srivastava as Senior Vice President of Clinical Development (June 25, 2024)
- MBX Biosciences Appoints Salomon (Sam) Azoulay, M.D, as Chief Medical Officer (June 25, 2024)
- Arvinas Appoints Andrew Saik as Chief Financial Officer and Treasurer (June 24, 2024)
- Avalo Therapeutics Appoints Paul Varki as Chief Legal Officer (June 24, 2024)
- MaaT Pharma Appoints Gianfranco Pittari, M.D., Ph.D., as Chief Medical Officer (June 24, 2024)
Who to call at Gain Therapeutics, and when
A new leader at Gain Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Gain Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Gain Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Gain Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Gain Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Gain Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.